Search Results for

*

1-3 of 3 ResultsHelp using search on aafp.org Sort by Relevance , Date , Title

Reslizumab (Cinqair) for Eosinophilic Asthma - STEPS - American Family Physician

Nov 15, 2017 - Reslizumab is an expensive treatment option for decreasing exacerbations in patients with severe asthma and pronounced eosinophilia. Because of the risk of anaphylaxis, it should only be administered in an appropriate facility by a medical professional. Reslizumab is best considered ...

American Family Physician : STEPS

https://www.aafp.org/afp/2017/1115/p671.html

Levalbuterol Tartrate (Xopenex HFA) for the Treatment of Bronchospasm - STEPS - ...

Jan 15, 2007 - Levalbuterol tartrate appears to be no more effective and offers no improvement in the side-effect profile compared with albuterol. The higher cost may make it appropriate for only a limited group of patients.

American Family Physician : STEPS

https://www.aafp.org/afp/2007/0115/p247.html

Omalizumab (Xolair) for Treatment of Asthma - STEPS - American Family Physician

Jan 15, 2005 - Omalizumab is an immunomodulatory therapy for the control of symptoms in patients with moderate to severe allergic asthma uncontrolled with conventional therapy. Given its high cost, the requirement that it be administered in a physician’s office, and side effects, it is appropriate for...

American Family Physician : STEPS

https://www.aafp.org/afp/2005/0115/p341.html

Page  1

25 50 100 results per page